• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估婴儿充血性心力衰竭的严重程度。

Grading the severity of congestive heart failure in infants.

作者信息

Ross R D, Bollinger R O, Pinsky W W

机构信息

Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit.

出版信息

Pediatr Cardiol. 1992 Apr;13(2):72-5. doi: 10.1007/BF00798207.

DOI:10.1007/BF00798207
PMID:1614922
Abstract

To determine which variables most accurately define congestive heart failure (CHF) in infants, 41 patients (median age 2.5 months) were graded by four pediatric cardiologists for the presence and severity of CHF based on the following variables: amount of formula consumed per feeding, feeding time, history of diaphoresis or tachypnea, growth parameters, respiratory and heart rates, respiratory pattern, perfusion, presence of edema, diastolic filling sounds, and hepatomegaly. There were 19 patients graded as having no CHF, nine as mild, seven moderate, and six severe CHF. The most sensitive and specific variables (p less than 0.0001) for the presence of CHF were a history of less than 3.5 oz/feed, respiratory rate greater than 50/min, an abnormal respiratory pattern, diastolic filling sounds, and hepatomegaly. Moderate to severe CHF was present when patients took less than 3 oz/feed or greater than 40 min/feed, had an abnormal respiratory pattern with a resting respiratory rate greater than 60/min, and had a diastolic filling sound and moderate hepatomegaly. Severe CHF was accompanied by a heart rate greater than 170/min, decreased perfusion, and severe hepatomegaly. Thus, the grading of the severity of CHF in infants should include an accurate description of these historical and clinical variables.

摘要

为了确定哪些变量能最准确地界定婴儿充血性心力衰竭(CHF),41名患者(中位年龄2.5个月)由四位儿科心脏病专家根据以下变量对CHF的存在及严重程度进行分级:每次喂养摄入的配方奶量、喂养时间、出汗或呼吸急促史、生长参数、呼吸和心率、呼吸模式、灌注情况、水肿的存在、舒张期充盈音以及肝肿大。有19名患者被分级为无CHF,9名轻度,7名中度,6名重度CHF。对于CHF存在最敏感和特异的变量(p小于0.0001)是每次喂养少于3.5盎司、呼吸频率大于50次/分钟、异常呼吸模式、舒张期充盈音以及肝肿大。当患者每次喂养少于3盎司或超过40分钟、静息呼吸频率大于60次/分钟且有异常呼吸模式、有舒张期充盈音和中度肝肿大时,存在中度至重度CHF。重度CHF伴有心率大于170次/分钟、灌注减少以及重度肝肿大。因此,婴儿CHF严重程度的分级应包括对这些病史和临床变量的准确描述。

相似文献

1
Grading the severity of congestive heart failure in infants.评估婴儿充血性心力衰竭的严重程度。
Pediatr Cardiol. 1992 Apr;13(2):72-5. doi: 10.1007/BF00798207.
2
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.急性心肌梗死后经多普勒超声心动图评估左心室舒张功能的临床方面
Dan Med Bull. 2001 Nov;48(4):199-210.
3
Plasma norepinephrine levels in infants and children with congestive heart failure.
Am J Cardiol. 1987 Apr 1;59(8):911-4. doi: 10.1016/0002-9149(87)91118-0.
4
[Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].[脑钠肽及N末端脑钠肽原在先天性心脏病患儿心功能评估中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Jun;11(6):429-32.
5
[Congenital heart disease and acquired valvular lesions in pregnancy].[妊娠期先天性心脏病与获得性瓣膜病变]
Herz. 2003 May;28(3):227-39. doi: 10.1007/s00059-003-2467-y.
6
Age-associated changes in diastolic filling: Doppler E/A ratio is not associated with congestive heart failure in the elderly.
South Med J. 1994 Jul;87(7):728-35.
7
[Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].[血浆脑钠肽前体浓度在小儿室间隔缺损合并充血性心力衰竭中的诊断价值]
Zhonghua Er Ke Za Zhi. 2005 Mar;43(3):161-4.
8
Lung sound patterns help to distinguish congestive heart failure, chronic obstructive pulmonary disease, and asthma exacerbations.肺部声音模式有助于区分充血性心力衰竭、慢性阻塞性肺疾病和哮喘加重。
Acad Emerg Med. 2012 Jan;19(1):79-84. doi: 10.1111/j.1553-2712.2011.01255.x.
9
Treatment of heart failure in infants and children.婴幼儿心力衰竭的治疗
Heart Dis. 2000 Sep-Oct;2(5):354-61.
10
Systolic and Diastolic Function in Congestive Heart Failure Pediatric Patients.充血性心力衰竭儿科患者的收缩和舒张功能
Rom J Intern Med. 2016 Jan-Mar;54(1):37-46. doi: 10.1515/rjim-2016-0004.

引用本文的文献

1
Pediatric heart failure: Current approach and treatment.小儿心力衰竭:当前的治疗方法与治疗手段
JHLT Open. 2025 Jun 27;9:100331. doi: 10.1016/j.jhlto.2025.100331. eCollection 2025 Aug.
2
End-stage paediatric heart failure in low- and middle-income countries: challenges in surgical management.低收入和中等收入国家的终末期小儿心力衰竭:外科治疗面临的挑战
Indian J Thorac Cardiovasc Surg. 2025 Jun;41(6):768-783. doi: 10.1007/s12055-024-01853-z. Epub 2024 Nov 25.
3
The Incidence of Heart Failure in Children with Congenital Heart Disease: A Prospective Cohort Study.

本文引用的文献

1
Vasodilator therapy for congestive heart failure.
J Pediatr. 1980 Apr;96(4):623-9. doi: 10.1016/s0022-3476(80)80726-8.
2
Fifteen-year experience with surgical repair of truncus arteriosus.动脉干手术修复的十五年经验。
J Thorac Cardiovasc Surg. 1985 Mar;89(3):414-22.
3
Valve replacement in children: guidelines for selection of prosthesis and timing of surgical intervention.
Ann Thorac Surg. 1987 Oct;44(4):398-403. doi: 10.1016/s0003-4975(10)63800-3.
4
先天性心脏病患儿心力衰竭的发病率:一项前瞻性队列研究。
Curr Cardiol Rev. 2025;21(5):15-21. doi: 10.2174/011573403X345783250128052038.
4
Case Ascertainment in Pediatric Heart Failure Using International Classification of Disease Clinical Modification (ICD-CM) Codes.使用国际疾病分类临床修订版(ICD-CM)编码确定小儿心力衰竭病例
Pediatr Cardiol. 2024 Nov 15. doi: 10.1007/s00246-024-03698-0.
5
Case Ascertainment in Pediatric Heart Failure Using International Classification of Disease Clinical Modification (ICD-CM) Codes.使用国际疾病分类临床修订版(ICD-CM)编码确定小儿心力衰竭病例
Res Sq. 2024 Oct 15:rs.3.rs-4941771. doi: 10.21203/rs.3.rs-4941771/v1.
6
Clinical Characteristics and Outcomes of Dilated Cardiomyopathy in Chinese Children: A Single-Center Retrospective Study.中国儿童扩张型心肌病的临床特征与预后:一项单中心回顾性研究
Children (Basel). 2024 Aug 15;11(8):992. doi: 10.3390/children11080992.
7
Pattern and determinants of health-related quality of life of adolescents with congenital heart disease in Cameroon: A single-center cross-sectional study.喀麦隆先天性心脏病青少年健康相关生活质量的模式及影响因素:一项单中心横断面研究。
JRSM Cardiovasc Dis. 2024 Apr 17;13:20480040241247396. doi: 10.1177/20480040241247396. eCollection 2024 Jan-Dec.
8
Diagnosis and Management of Pediatric Heart Failure.儿科心力衰竭的诊断与治疗。
Indian J Pediatr. 2023 May;90(5):492-500. doi: 10.1007/s12098-022-04433-4. Epub 2023 Mar 16.
9
Insights and perspectives into clinical biomarker discovery in pediatric heart failure and congenital heart disease-a narrative review.小儿心力衰竭和先天性心脏病临床生物标志物发现的见解与展望——一篇叙述性综述
Cardiovasc Diagn Ther. 2023 Feb 28;13(1):83-99. doi: 10.21037/cdt-22-386. Epub 2023 Jan 9.
10
The value of cardiac magnetic resonance imaging in endocardial fibroelastosis.心脏磁共振成像在内膜弹力纤维增生症中的价值。
Front Pediatr. 2022 Nov 1;10:874597. doi: 10.3389/fped.2022.874597. eCollection 2022.
Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure.
J Am Coll Cardiol. 1987 Sep;10(3):608-18. doi: 10.1016/s0735-1097(87)80204-8.
5
Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics.轻度充血性心力衰竭中正常神经激素活性的鉴定以及直立姿势和利尿剂的刺激作用。
Am J Cardiol. 1987 Dec 1;60(16):1322-8. doi: 10.1016/0002-9149(87)90615-1.
6
A controlled trial of digoxin in congestive heart failure.
Am J Cardiol. 1988 Feb 1;61(4):371-5. doi: 10.1016/0002-9149(88)90947-2.
7
Long-term results after the Fontan operation for tricuspid atresia.
Circulation. 1987 Mar;75(3):605-10. doi: 10.1161/01.cir.75.3.605.
8
The Fontan operation. Ventricular hypertrophy, age, and date of operation as risk factors.
J Thorac Cardiovasc Surg. 1986 Dec;92(6):1049-64.
9
Current risks and protocols for operations for double-outlet right ventricle. Derivation from an 18 year experience.
J Thorac Cardiovasc Surg. 1986 Nov;92(5):913-30.
10
Septation of the univentricular heart. Transatrial approach.
J Thorac Cardiovasc Surg. 1979 Sep;78(3):423-30.